FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for venlafaxine by BluePoint Laboratories, expanding its generic availability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Panic Disorder
• Social Anxiety Disorder

Drugs mentioned

• Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)